{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:54:07Z","timestamp":1769090047364,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSC 101-2325-B-002-066"],"award-info":[{"award-number":["NSC 101-2325-B-002-066"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSC 102-2325-B-002-062"],"award-info":[{"award-number":["NSC 102-2325-B-002-062"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["Most 103-2325-B-002-002"],"award-info":[{"award-number":["Most 103-2325-B-002-002"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["grant 104C101-61"],"award-info":[{"award-number":["grant 104C101-61"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH research funding account MG151"],"award-info":[{"award-number":["NTUH research funding account MG151"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12933-017-0522-x","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T03:05:19Z","timestamp":1491879919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Human serum RNase-L level is inversely associated with metabolic syndrome and age"],"prefix":"10.1186","volume":"16","author":[{"given":"Yi-Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Huei","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Der-Sheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chiao","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen-Yu","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Shiung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,11]]},"reference":[{"key":"522_CR1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/164_2015_12","volume":"233","author":"S Ben-Shmuel","year":"2016","unstructured":"Ben-Shmuel S, Rostoker R, Scheinman EJ, LeRoith D. Metabolic syndrome, type 2 diabetes, and cancer: epidemiology and potential mechanisms. Handb Exp Pharmacol. 2016;233:355\u201372.","journal-title":"Handb Exp Pharmacol"},{"key":"522_CR2","first-page":"943162","volume":"2014","author":"J Kaur","year":"2014","unstructured":"Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162.","journal-title":"Cardiol Res Pract"},{"key":"522_CR3","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1291\/hypres.31.1283","volume":"31","author":"E Oda","year":"2008","unstructured":"Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res: Off J Jpn Soc Hypertens. 2008;31:1283\u201391.","journal-title":"Hypertens Res: Off J Jpn Soc Hypertens"},{"key":"522_CR4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cjca.2014.11.010","volume":"31","author":"A Pucci","year":"2015","unstructured":"Pucci A, Finer N. New medications for treatment of obesity: metabolic and cardiovascular effects. Can J Cardiol. 2015;31:142\u201352.","journal-title":"Can J Cardiol"},{"key":"522_CR5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacl.2013.04.001","volume":"7","author":"HE Bays","year":"2013","unstructured":"Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, et al. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013;7:304\u201383.","journal-title":"J Clin Lipidol"},{"key":"522_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11154-014-9301-0","volume":"15","author":"N Kloting","year":"2014","unstructured":"Kloting N, Bluher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15:277\u201387.","journal-title":"Rev Endocr Metab Disord"},{"key":"522_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","volume":"105","author":"N Esser","year":"2014","unstructured":"Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105:141\u201350.","journal-title":"Diabetes Res Clin Pract"},{"key":"522_CR8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s12026-015-8783-5","volume":"64","author":"SI Vlaicu","year":"2016","unstructured":"Vlaicu SI, Tatomir A, Boodhoo D, Vesa S, Mircea PA, Rus H. The role of complement system in adipose tissue-related inflammation. Immunol Res. 2016;64:653\u201364.","journal-title":"Immunol Res"},{"key":"522_CR9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12933-016-0441-2","volume":"15","author":"V Moreno-Viedma","year":"2016","unstructured":"Moreno-Viedma V, Amor M, Sarabi A, Bilban M, Staffler G, Zeyda M, et al. Common dysregulated pathways in obese adipose tissue and atherosclerosis. Cardiovasc Diabetol. 2016;15:120.","journal-title":"Cardiovasc Diabetol"},{"key":"522_CR10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diabetes.53.3.693","volume":"53","author":"FB Hu","year":"2004","unstructured":"Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes. 2004;53:693\u2013700.","journal-title":"Diabetes"},{"key":"522_CR11","first-page":"272","volume":"84","author":"B Zinman","year":"1999","unstructured":"Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG. Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999;84:272\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"522_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/jir.2010.0107","volume":"31","author":"H Kristiansen","year":"2011","unstructured":"Kristiansen H, Gad HH, Eskildsen-Larsen S, Despres P, Hartmann R. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res. 2011;31:41\u20137.","journal-title":"J Interferon Cytokine Res"},{"key":"522_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jir.2010.0120","volume":"31","author":"A Chakrabarti","year":"2011","unstructured":"Chakrabarti A, Jha BK, Silverman RH. New insights into the role of RNase L in innate immunity. J Interferon Cytokine Res. 2011;31:49\u201357.","journal-title":"J Interferon Cytokine Res"},{"key":"522_CR14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.biochi.2007.02.006","volume":"89","author":"C Bisbal","year":"2007","unstructured":"Bisbal C, Silverman RH. Diverse functions of RNase L and implications in pathology. Biochimie. 2007;89:789\u201398.","journal-title":"Biochimie"},{"key":"522_CR15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/jir.2013.0147","volume":"34","author":"SE Brennan-Laun","year":"2014","unstructured":"Brennan-Laun SE, Ezelle HJ, Li XL, Hassel BA. RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting. J Interferon Cytokine Res. 2014;34:275\u201388.","journal-title":"J Interferon Cytokine Res"},{"key":"522_CR16","doi-asserted-by":"crossref","first-page":"e7563","DOI":"10.1371\/journal.pone.0007563","volume":"4","author":"T Salehzada","year":"2009","unstructured":"Salehzada T, Cambier L, Vu Thi N, Manchon L, Regnier L, Bisbal C. Endoribonuclease L (RNase L) regulates the myogenic and adipogenic potential of myogenic cells. PLoS ONE. 2009;4:e7563.","journal-title":"PLoS ONE"},{"key":"522_CR17","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1128\/MCB.20.14.4959-4969.2000","volume":"20","author":"C Bisbal","year":"2000","unstructured":"Bisbal C, Silhol M, Laubenthal H, Kaluza T, Carnac G, Milligan L, et al. The 2\u2032-5\u2032 oligoadenylate\/RNase L\/RNase L inhibitor pathway regulates both MyoD mRNA stability and muscle cell differentiation. Mol Cell Biol. 2000;20:4959\u201369.","journal-title":"Mol Cell Biol"},{"key":"522_CR18","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/onc.2009.16","volume":"28","author":"W Al-Ahmadi","year":"2009","unstructured":"Al-Ahmadi W, Al-Haj L, Al-Mohanna FA, Silverman RH, Khabar KS. RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth. Oncogene. 2009;28:1782\u201391.","journal-title":"Oncogene"},{"key":"522_CR19","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1093\/nar\/gks545","volume":"40","author":"L Al-Haj","year":"2012","unstructured":"Al-Haj L, Blackshear PJ, Khabar KS. Regulation of p21\/CIP1\/WAF-1 mediated cell-cycle arrest by RNase L and tristetraprolin, and involvement of AU-rich elements. Nucleic Acids Res. 2012;40:7739\u201352.","journal-title":"Nucleic Acids Res"},{"key":"522_CR20","doi-asserted-by":"crossref","first-page":"e2458","DOI":"10.1038\/cddis.2016.323","volume":"7","author":"YT Wang","year":"2016","unstructured":"Wang YT, Chiang HH, Huang YS, Hsu CL, Yang PJ, Juan HF, et al. A link between adipogenesis and innate immunity: RNase-L promotes 3T3-L1 adipogenesis by destabilizing Pref-1 mRNA. Cell Death Dis. 2016;7:e2458.","journal-title":"Cell Death Dis."},{"key":"522_CR21","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/cdd.2012.23","volume":"19","author":"O Fabre","year":"2012","unstructured":"Fabre O, Salehzada T, Lambert K, Boo Seok Y, Zhou A, Mercier J, et al. RNase L controls terminal adipocyte differentiation, lipids storage and insulin sensitivity via CHOP10 mRNA regulation. Cell Death Differ. 2012;19:1470\u201381.","journal-title":"Cell Death Differ"},{"key":"522_CR22","doi-asserted-by":"crossref","first-page":"e1136","DOI":"10.1038\/cddis.2014.104","volume":"5","author":"O Fabre","year":"2014","unstructured":"Fabre O, Breuker C, Amouzou C, Salehzada T, Kitzmann M, Mercier J, et al. Defects in TLR3 expression and RNase L activation lead to decreased MnSOD expression and insulin resistance in muscle cells of obese people. Cell Death Dis. 2014;5:e1136.","journal-title":"Cell Death Dis."},{"key":"522_CR23","doi-asserted-by":"crossref","first-page":"e001820","DOI":"10.1161\/JAHA.115.001820","volume":"4","author":"CS Hung","year":"2015","unstructured":"Hung CS, Tseng PH, Tu CH, Chen CC, Liao WC, Lee YC, et al. Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population. J Am Heart Assoc. 2015;4:e001820.","journal-title":"J Am Heart Assoc."},{"key":"522_CR24","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640\u20135.","journal-title":"Circulation"},{"key":"522_CR25","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J. Group IDFETFC. The metabolic syndrome\u2014a new worldwide definition. Lancet. 2005;366:1059\u201362.","journal-title":"Lancet"},{"key":"522_CR26","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"522_CR27","doi-asserted-by":"crossref","first-page":"e108230","DOI":"10.1371\/journal.pone.0108230","volume":"9","author":"D-S Han","year":"2014","unstructured":"Han D-S, Chu-Su Y, Chiang C-K, Tseng F-Y, Tseng P-H, Chen C-L, et al. Serum myostatin is reduced in individuals with metabolic syndrome. PLoS ONE. 2014;9:e108230.","journal-title":"PLoS ONE"},{"key":"522_CR28","first-page":"1","volume":"149","author":"JR Crowther","year":"2000","unstructured":"Crowther JR. The ELISA guidebook. Methods Mol Biol. 2000;149:1\u2013413.","journal-title":"Methods Mol Biol."},{"key":"522_CR29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jim.2012.01.010","volume":"377","author":"KM Jaedicke","year":"2012","unstructured":"Jaedicke KM, Taylor JJ, Preshaw PM. Validation and quality control of ELISAs for the use with human saliva samples. J Immunol Methods. 2012;377:62\u20135.","journal-title":"J Immunol Methods"},{"key":"522_CR30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","volume":"11","author":"N Ouchi","year":"2011","unstructured":"Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11:85\u201397.","journal-title":"Nat Rev Immunol"},{"key":"522_CR31","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00394-015-0993-z","volume":"55","author":"M Siervo","year":"2016","unstructured":"Siervo M, Lara J, Celis-Morales C, Vacca M, Oggioni C, Battezzati A, et al. Age-related changes in basal substrate oxidation and visceral adiposity and their association with metabolic syndrome. Eur J Nutr. 2016;55:1755\u201367.","journal-title":"Eur J Nutr"},{"key":"522_CR32","doi-asserted-by":"crossref","first-page":"e0169289","DOI":"10.1371\/journal.pone.0169289","volume":"12","author":"SA Cho","year":"2017","unstructured":"Cho SA, Joo HJ, Cho JY, Lee SH, Park JH, Hong SJ, et al. Visceral fat area and serum adiponectin level predict the development of metabolic syndrome in a community-based asymptomatic population. PLoS ONE. 2017;12:e0169289.","journal-title":"PLoS ONE"},{"key":"522_CR33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12933-016-0479-1","volume":"15","author":"Y Obata","year":"2016","unstructured":"Obata Y, Maeda N, Yamada Y, Yamamoto K, Nakamura S, Yamaoka M, et al. Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects. Cardiovasc Diabetol. 2016;15:159.","journal-title":"Cardiovasc Diabetol"},{"key":"522_CR34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/MOL.0000000000000276","volume":"27","author":"MD Abou Ziki","year":"2016","unstructured":"Abou Ziki MD, Mani A. Metabolic syndrome: genetic insights into disease pathogenesis. Curr Opin Lipidol. 2016;27:162\u201371.","journal-title":"Curr Opin Lipidol"},{"key":"522_CR35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.urolonc.2012.07.011","volume":"31","author":"MJ Alvarez-Cubero","year":"2013","unstructured":"Alvarez-Cubero MJ, Saiz M, Martinez-Gonzalez LJ, Alvarez JC, Lorente JA, Cozar JM. Genetic analysis of the principal genes related to prostate cancer: a review. Urol Oncol. 2013;31:1419\u201329.","journal-title":"Urol Oncol."},{"key":"522_CR36","doi-asserted-by":"crossref","unstructured":"Martyniak K, Masternak MM. Changes in adipose tissue cellular composition during obesity and aging as a cause of metabolic dysregulation. Exp Gerontol. 2016.","DOI":"10.1016\/j.exger.2016.12.007"},{"issue":"Suppl 2","key":"522_CR37","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.2337\/dc09-S304","volume":"32","author":"P Iozzo","year":"2009","unstructured":"Iozzo P. Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue. Diabetes Care. 2009;32(Suppl 2):S168\u201373.","journal-title":"Diabetes Care."},{"key":"522_CR38","first-page":"403","volume":"10","author":"NB Kasim","year":"2016","unstructured":"Kasim NB, Huri HZ, Vethakkan SR, Ibrahim L, Abdullah BM. Genetic polymorphisms associated with overweight and obesity in uncontrolled type 2 diabetes mellitus. BiomarkMedicine. 2016;10:403\u201315.","journal-title":"BiomarkMedicine."},{"key":"522_CR39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.genom.7.080505.115715","volume":"7","author":"AK Agarwal","year":"2006","unstructured":"Agarwal AK, Garg A. Genetic disorders of adipose tissue development, differentiation, and death. Annu Rev Genom Hum Genet. 2006;7:175\u201399.","journal-title":"Annu Rev Genom Hum Genet"},{"key":"522_CR40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11373-008-9261-z","volume":"15","author":"JY Lu","year":"2008","unstructured":"Lu JY, Huang KC, Chang LC, Huang YS, Chi YC, Su TC, et al. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond. J Biomed Sci. 2008;15:565\u201376.","journal-title":"J Biomed Sci"},{"key":"522_CR41","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1210\/jcem.86.8.7741","volume":"86","author":"WS Yang","year":"2001","unstructured":"Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"522_CR42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1475-2840-13-103","volume":"13","author":"EZ Fisman","year":"2014","unstructured":"Fisman EZ, Tenenbaum A. Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? Cardiovasc Diabetol. 2014;13:103.","journal-title":"Cardiovasc Diabetol"},{"key":"522_CR43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","volume":"77","author":"P Tontonoz","year":"2008","unstructured":"Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem. 2008;77:289\u2013312.","journal-title":"Annu Rev Biochem"},{"key":"522_CR44","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/diacare.25.2.376","volume":"25","author":"WS Yang","year":"2002","unstructured":"Yang WS, Jeng CY, Wu TJ, Tanaka S, Funahashi T, Matsuzawa Y, et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care. 2002;25:376\u201380.","journal-title":"Diabetes Care"},{"key":"522_CR45","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1194\/jlr.M048710","volume":"55","author":"RR Singaraja","year":"2014","unstructured":"Singaraja RR, Tietjen I, Hovingh GK, Franchini PL, Radomski C, Wong K, et al. Identification of four novel genes contributing to familial elevated plasma HDL cholesterol in humans. J Lipid Res. 2014;55:1693\u2013701.","journal-title":"J Lipid Res"},{"key":"522_CR46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0006-291X(86)91112-5","volume":"140","author":"CH Wang","year":"1986","unstructured":"Wang CH, Wu JM. Age-related differences in the induction of 2-5A synthetase and 2-5A dependent binding protein activities by interferon in guinea pig peritoneal macrophages. Biochem Biophys Res Commun. 1986;140:455\u201360.","journal-title":"Biochem Biophys Res Commun"},{"key":"522_CR47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0047-6374(93)90115-8","volume":"67","author":"K Pfeifer","year":"1993","unstructured":"Pfeifer K, Ushijima H, Lorenz B, Muller WE, Schroder HC. Evidence for age-dependent impairment of antiviral 2\u2032,5\u2032-oligoadenylate synthetase\/ribonuclease L-system in tissues of rat. Mech Ageing Dev. 1993;67:101\u201314.","journal-title":"Mech Ageing Dev"},{"key":"522_CR48","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/sj.onc.1210111","volume":"26","author":"JB Andersen","year":"2007","unstructured":"Andersen JB, Li XL, Judge CS, Zhou A, Jha BK, Shelby S, et al. Role of 2-5A-dependent RNase-L in senescence and longevity. Oncogene. 2007;26:3081\u20138.","journal-title":"Oncogene"},{"key":"522_CR49","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.exger.2005.09.004","volume":"40","author":"N Chondrogianni","year":"2005","unstructured":"Chondrogianni N, Gonos ES. Proteasome dysfunction in mammalian aging: steps and factors involved. Exp Gerontol. 2005;40:931\u20138.","journal-title":"Exp Gerontol"},{"key":"522_CR50","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.ajpath.2011.11.012","volume":"180","author":"U Tomaru","year":"2012","unstructured":"Tomaru U, Takahashi S, Ishizu A, Miyatake Y, Gohda A, Suzuki S, et al. Decreased proteasomal activity causes age-related phenotypes and promotes the development of metabolic abnormalities. Am J Pathol. 2012;180:963\u201372.","journal-title":"Am J Pathol"},{"key":"522_CR51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2710.2006.00761.x","volume":"31","author":"KI Kim","year":"2006","unstructured":"Kim KI, Kim SR, Sasase N, Taniguchi M, Harada S, Kinoshita K, et al. 2\u2032-,5\u2032-Oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C. J Clin Pharm Ther. 2006;31:441\u20136.","journal-title":"J Clin Pharm Ther"},{"key":"522_CR52","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1872-034X.2008.00397.x","volume":"38","author":"M Shindo","year":"2008","unstructured":"Shindo M, Hamada K, Morikawa T, Harano Y, Nakajima T, Okuno T. In vivo interferon system assessed by 2\u2032-5\u2032 oligoadenylate synthetase activity in chronic hepatitis C virus patients treated with pegylated interferon and ribavirin. Hepatology Res. 2008;38:1213\u201320.","journal-title":"Hepatology Res"},{"key":"522_CR53","doi-asserted-by":"crossref","first-page":"11898","DOI":"10.1128\/JVI.01003-10","volume":"84","author":"H Kristiansen","year":"2010","unstructured":"Kristiansen H, Scherer CA, McVean M, Iadonato SP, Vends S, Thavachelvam K, et al. Extracellular 2\u2032-5\u2032 oligoadenylate synthetase stimulates RNase L-independent antiviral activity: a novel mechanism of virus-induced innate immunity. J Virol. 2010;84:11898\u2013904.","journal-title":"J Virol"},{"key":"522_CR54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/imm.12560","volume":"147","author":"AA Dar","year":"2016","unstructured":"Dar AA, Pradhan TN, Kulkarni DP, Shah SU, Rao KV, Chaukar DA, et al. Extracellular 2\u20325\u2032-oligoadenylate synthetase 2 mediates T-cell receptor CD3-zeta chain down-regulation via caspase-3 activation in oral cancer. Immunology. 2016;147:251\u201364.","journal-title":"Immunology"},{"key":"522_CR55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1742-2094-11-67","volume":"11","author":"JP Rivero Vaccari de","year":"2014","unstructured":"de Rivero Vaccari JP, Brand FJ 3rd, Sedaghat C, Mash DC, Dietrich WD, Keane RW. RIG-1 receptor expression in the pathology of Alzheimer\u2019s disease. J Neuroinflamm. 2014;11:67.","journal-title":"J Neuroinflamm"},{"key":"522_CR56","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.4049\/jimmunol.181.10.7324","volume":"181","author":"MJ Kim","year":"2008","unstructured":"Kim MJ, Yoo JY. Active caspase-1-mediated secretion of retinoic acid inducible gene-I. J Immunol. 2008;181:7324\u201331.","journal-title":"J Immunol"},{"key":"522_CR57","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.chom.2015.02.010","volume":"17","author":"A Chakrabarti","year":"2015","unstructured":"Chakrabarti A, Banerjee S, Franchi L, Loo YM, Gale M Jr, Nunez G, et al. RNase L activates the NLRP3 inflammasome during viral infections. Cell Host Microb. 2015;17:466\u201377.","journal-title":"Cell Host Microb"},{"key":"522_CR58","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.179.3.1913","volume":"179","author":"Y Qu","year":"2007","unstructured":"Qu Y, Franchi L, Nunez G, Dubyak GR. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol. 2007;179:1913\u201325.","journal-title":"J Immunol"},{"key":"522_CR59","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/ATVBAHA.111.244061","volume":"32","author":"ZL Li","year":"2012","unstructured":"Li ZL, Woollard JR, Ebrahimi B, Crane JA, Jordan KL, Lerman A, et al. Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis. Arterioscler Thromb Vasc Biol. 2012;32:1132\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-017-0522-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T14:22:51Z","timestamp":1719152571000},"score":1,"resource":{"primary":{"URL":"http:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-017-0522-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,11]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["522"],"URL":"https:\/\/doi.org\/10.1186\/s12933-017-0522-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,11]]},"article-number":"46"}}